A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats

Behavioural Brain Research

Volumn 238, Issue 1, 2013, Pages 109-112

  Pałucha Poniewiera, Agnieszka ^a   Pilc, Andrzej ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

AMN082; Antidepressant; Forced swim test; MGlu7 receptor; MMPIP

Indexed keywords

[6 (4 METHOXYPHENYL) 5 METHYL 3 PYRIDIN 4 YLISOXAZOLO[4,5 C]PYRIDIN 4 (5H) ONE]; ANTIDEPRESSANT AGENT; METABOTROPIC RECEPTOR 7; METABOTROPIC RECEPTOR ANTAGONIST; N,N' DIBENZHYDRYLETHANE 1,2 DIAMINE; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FORCED SWIMMING TEST; LOCOMOTION; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; SEROTONINERGIC SYSTEM;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BENZHYDRYL COMPOUNDS; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; PYRIDONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; SWIMMING;

EID: 84868548555     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.10.004     Document Type: Article

References (18)

1. Chaki S., Hikichi H. Targeting of metabotropic glutamate receptors for the treatment of schizophrenia. Current Pharmaceutical Design 2011, 17:94-102.
2. Chiechio S., Nicoletti F. Metabotropic glutamate receptors and the control of chronic pain. Current Opinion in Pharmacology 2012, 12:28-34.
3. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annual Review of Pharmacology and Toxicology 1997, 37:205-237.
4. Cryan J.F., Kelly P.H., Neijt H.C., Sansig G., Flor P.J., van der Putten H. Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. European Journal of Neuroscience 2003, 17:2409-2417.
5. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
6. Hikichi H., Murai T., Okuda S., Maehara S., Satow A., Ise S., et al. Effects of a novel metabotropic glutamate receptor 7 negative allosteric modulator, 6-(4-methoxyphenyl)-5-methyl-3-pyridin-4-ylisoxazonolo[4,5-c]pyridin-4(5H)-one (MMPIP), on the central nervous system in rodents. European Journal of Pharmacology 2010, 639:106-114.
7. Masugi M., Yokoi M., Shigemoto R., Muguruma K., Watanabe Y., Sansig G., et al. Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion. Journal of Neuroscience 1999, 19:955-963.
8. Mc Geer P.L., Eccles J.C., Mc Geer E.G. Molecular Neurobiology of the Mammalian Brain 1987, Plenum Press, New York.
9. Mitsukawa K., Mombereau C., Lötscher E., Uzunov D.P., van der Putten H., Flor P.J., et al. Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology 2006, 31:1112-1122.
10. Mitsukawa K., Yamamoto R., Ofner S., Nozulak J., Pescott O., Lukic S., et al. A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:18712-18717.
11. Nicoletti F., Bockaert J., Collingridge G.L., Conn P.J., Ferraguti F., Schoepp D.D., et al. Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 2011, 60:1017-1041.
12. Page M.E., Detke M.J., Dalvi A., Kirby L.G., Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology 1999, 147:162-167.
13. Pałucha A., Kłak K., Brański P., van der Putten H., Flor P.J., Pilc A. Activation of the mGlu7 receptor elicits antidepressant-like effects in mice. Psychopharmacology 2007, 194:555-562.
14. Pałucha A., Pilc A. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacology and Therapeutics 2007, 115:116-147.
15. Pałucha-Poniewiera A., Brański P., Lenda T., Pilc A. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent. Journal of Pharmacology and Experimental Therapeutics 2010, 334:1066-1074.
16. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. European Journal of Pharmacology 1978, 47:379-391.
17. Sukoff Rizzo S.J., Leonard S.K., Gilbert A., Dollings P., Smith D.L., Zhang M.Y., et al. The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?. Journal of Pharmacology and Experimental Therapeutics 2011, 338:345-352.
18. Suzuki G., Tsukamoto N., Fushiki H., Kawagishi A., Nakamura M., Kurihara H., et al. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists. Journal of Pharmacology and Experimental Therapeutics 2007, 323:147-156.